Headline News about AbbVie
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://g.foolcdn.com/editorial/images/777844/a-couple-of-people-looking-at-charts.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Evolus: Chiseling Away At The Aesthetic Market
May 25, 2024
Via Talk Markets
![](https://g.foolcdn.com/editorial/images/778414/passive-income.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
This Is What Whales Are Betting On AbbVie
May 22, 2024
Via Benzinga
![](https://g.foolcdn.com/editorial/images/778200/gettyimages-1720247749.jpg)
![](https://g.foolcdn.com/editorial/images/777723/two-scientists-review-data-in-lab-bench.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
The Analyst Verdict: AbbVie In The Eyes Of 5 Experts
May 17, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/05/24/Crypto-hack-Photo-by-Bits-And-Splits-on-.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/04/buy_the_dip_stocks_1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/options_image_2.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2021/10/high-yield-percentage-1600.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/safe-haven-1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_18.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5.jpeg?width=1200&height=800&fit=crop)
(ABBV) - Analyzing AbbVie's Short Interest
May 10, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/03/sp500_1600-1024x576.png)
![](https://g.foolcdn.com/editorial/images/777695/investor-sofa-laptop-getty.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/17/dalle_2024-05-17_18.49.22_-_.jpeg?width=1200&height=800&fit=crop)
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch
May 18, 2024
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![](https://g.foolcdn.com/editorial/images/777794/gettyimages-1720247749.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/17/AbbVie-Office.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/10/valuestocks_1600_03.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/retire-retirement-ahead-sign.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/05/13/dalle_2024-05-13_18.59.57_-_.jpeg?width=1200&height=800&fit=crop)
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
May 14, 2024
Via Benzinga
Topics
Cannabis
Exposures
Cannabis
![](https://g.foolcdn.com/editorial/images/776733/physician-shaking-patients-hand.jpg)
![](https://g.foolcdn.com/editorial/images/776819/financial-analysis-company-filing-business-papers.jpg)
![](https://talkmarkets.com/images/logos/talkmarkets.png)
![](https://g.foolcdn.com/editorial/images/776930/copy-of-dividends-blackboard-sketch-doodle.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.